ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007